long half-life and large variability [Regulatives / Guidelines]

posted by martin  – Austria, 2020-07-29 22:49 (83 d 23:03 ago) – Posting: # 21801
Views: 1,217

dear ElMaestro,

Thank you for your swift reply and sharing your thoughts.

There are two types of covariates (type 1: continous = subject specfic values; and type 2: categorical variable with a few levels).

At the first glance a different regulatory pathway might be worth considering based on a PK or exposure similarity evalulation as in such a case there could be more flexibility regarding acceptance of statistical models used to test for equivalence in PK metrics.

Happy to get your thoughts on this idea.

best regards


Complete thread:

 Admin contact
21,174 posts in 4,412 threads, 1,476 registered users;
online 6 (0 registered, 6 guests [including 2 identified bots]).
Forum time: Wednesday 21:52 CEST (Europe/Vienna)

But it is in matters beyond the limits of mere rule
that the skill of the analyst is evinced.
He makes in silence a host of observations and inferences…    Edgar Allan Poe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz